Aim & Scope
Pharmacy and Drug Development (ISSN: 2836-2322) is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological disciplines.
Pharmacy and Drug Development (ISSN: 2836-2322) is originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society, encompassing a broad spectrum of scientific research and technological disciplines.
Pharmacy and Drug Development (ISSN: 2836-2322) is an Open Access single blinded peer-reviewed medical journal, publish original research articles, review papers, clinical studies, case reports, editorials, and perspectives etc. It seeks support from individuals, institutes, libraries, universities, funding agencies, and others.
Pharmacy and Drug Development (ISSN: 2836-2322) focuses on drug-related disorders, pharmacological complications, therapeutic innovations, formulation challenges, and clinical applications of new medicines.
The current research in Pharmacy and Drug Development (ISSN: 2836-2322) involves the development of new techniques to minimize these ailments and provides knowledge for researchers, practitioners, and even common people.
Pharmacy and Drug Development (ISSN: 2836-2322) accepts the articles in the fields of pharmacology, Pharmaceutics, Pharmacodynamics, Pharmacokinetics, Drug metabolism, Drug formulation, Active pharmaceutical ingredients (APIs), Excipients, Dosage forms, Drug compounding, Biopharmaceutics, Drug design, Medicinal chemistry, High-throughput screening (HTS), Lead optimization, Structure-activity relationship (SAR), Computer-aided drug design (CADD), Preclinical research, In vitro and in vivo studies, Clinical trials (Phase I, II, III, IV), Small-molecule drugs, Biologics, Monoclonal antibodies, Peptide drugs, Vaccines, Gene therapy, RNA therapeutics (mRNA, siRNA), Biosimilars, Nanomedicine, Receptor binding, Agonists and antagonists, Enzyme inhibitors, Drug-drug interactions, Side effects (Adverse drug reactions - ADRs), Therapeutic index, Bioavailability, First-pass metabolism, Tablets and capsules, Parenteral drugs (IV, IM, SC), Transdermal patches, Controlled-release formulations, Liposomal drug delivery, Nanoparticle drug carriers, Implantable drug delivery systems, Post-marketing surveillance, Personalized medicine, Pharmacogenomics, Artificial intelligence in drug discovery, 3D printing of drugs, Digital therapeutics.
Authors can contribute their valuable submission through online and/or to info@mediresonline.org
Pharmacology: Pharmacology is the branch of medical science that studies drugs, including their origin, chemical properties, biological effects, and therapeutic uses. It focuses on how drugs interact with the body to treat, prevent, or diagnose diseases.
Pharmaceutics: Pharmaceutics is the branch of pharmacy that focuses on the formulation, preparation, and delivery of drugs in a safe and effective manner. It involves designing dosage forms such as tablets, capsules, injections, and ointments to ensure proper absorption, stability, and therapeutic effect in the body.
Pharmacodynamics: Pharmacodynamics is the study of how drugs affect the body, including their mechanisms of action, the relationship between drug concentration and effect, and the physiological and biochemical responses they elicit. It explains what a drug does to the body at the cellular and systemic levels.
Pharmacokinetics: Pharmacokinetics is the study of how drugs move through the body over time, encompassing their absorption, distribution, metabolism, and excretion. It helps determine the onset, intensity, and duration of a drug’s effect.
Drug metabolism: Drug metabolism is the biochemical process by which the body chemically alters drugs, primarily in the liver, to facilitate their elimination. This process transforms active drugs into more water-soluble metabolites for easier excretion, often affecting the drug’s activity and duration of action.
Drug formulation: Drug formulation refers to the process of designing and preparing a pharmaceutical product by combining the active drug with suitable excipients to ensure stability, efficacy, and patient-friendly administration. It involves creating the final dosage form, such as tablets, capsules, or injections, that delivers the drug safely and effectively.
Active pharmaceutical ingredients (APIs): Active Pharmaceutical Ingredients (APIs) are the biologically active components in a drug that produce the intended therapeutic effects. They are the primary substances responsible for treating, diagnosing, or preventing diseases, and are combined with excipients to formulate the final medicinal product.
Excipients: Excipients are inactive substances formulated alongside the active ingredient of a medication. They serve as carriers, stabilizers, or enhancers of the drug’s delivery, absorption, taste, and appearance, without producing therapeutic effects themselves.
Dosage forms: Dosage forms are the physical forms in which a drug is produced and administered to patients, such as tablets, capsules, injections, ointments, or liquids. They are designed to ensure the drug’s stability, effectiveness, and proper delivery to the body.
Drug compounding: Drug compounding is the process of preparing personalized medications by mixing, combining, or altering ingredients to create a specific formulation that meets an individual patient’s needs. It is often used when commercially available drugs are unsuitable in dosage, form, or strength.
